Log In
Print this Print this

NIP-022, ONO-7746

  Manage Alerts
Collapse Summary General Information
Company Nissan Chemical Industries Ltd.
DescriptionThrombopoietin (TPO) receptor (CD110; Mpl) activator
Molecular Target Thrombopoietin (TPO) receptor (CD110) (Mpl)
Mechanism of ActionThrombopoietin (TPO) receptor (CD110) (Mpl) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationThrombocytopenia
Indication DetailsTreat thrombocytopenia
Regulatory Designation
PartnerOno Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today